Long-term maintenance with intramuscular ketamine for treatment-resistant bipolar II depression

American Journal of Psychiatry

Volumn 169, Issue 8, 2012, Pages 868-869

  Cusin, Cristina ^a   Hilton, George Q ^a   Nierenberg, Andrew A ^a   Fava, Maurizio ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ARMODAFINIL; KETAMINE; LAMOTRIGINE; LEVOTHYROXINE; METHYLPHENIDATE; MONOAMINE OXIDASE INHIBITOR; MOOD STABILIZER; OXCARBAZEPINE; PREGABALIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; ATTENTION DEFICIT DISORDER; BIPOLAR II DISORDER; CASE REPORT; DEPRESSION; DISSOCIATIVE DISORDER; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; ELECTROCONVULSIVE THERAPY; FEMALE; FIBROMYALGIA; HUMAN; HYPOTHYROIDISM; IRRITABILITY; LETTER; LONG TERM CARE; NIGHTMARE; PRIORITY JOURNAL; SIDE EFFECT; SUICIDAL IDEATION;

EID: 84864807084     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2012.12020219     Document Type: Letter

References (2)

1. Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK: A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006; 63:856-864
2. Zarate CA Jr Brutsche NE Ibrahim L Franco-Chaves J Diazgranados N Cravchik A Selter J Marquardt CA Liberty V Luckenbaugh DA: Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry 2012 71:939-946